Amer E. Alkhalifa

646 total citations · 1 hit paper
16 papers, 415 citations indexed

About

Amer E. Alkhalifa is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Amer E. Alkhalifa has authored 16 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Physiology and 3 papers in Oncology. Recurrent topics in Amer E. Alkhalifa's work include Alzheimer's disease research and treatments (5 papers), Cancer Mechanisms and Therapy (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Amer E. Alkhalifa is often cited by papers focused on Alzheimer's disease research and treatments (5 papers), Cancer Mechanisms and Therapy (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Amer E. Alkhalifa collaborates with scholars based in United States, Jordan and Türkiye. Amer E. Alkhalifa's co-authors include Nour F. Al-Ghraiybah, Amal Kaddoumi, Nehad M. Ayoub, Kamal M. Al-Shami, Andrew B. Roberts, Junwei Wang, Aymen Shatnawi, Ahmed Alhusban, Belal Al‐Husein and Mohammad A. Hassan and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and Frontiers in Pharmacology.

In The Last Decade

Amer E. Alkhalifa

15 papers receiving 413 citations

Hit Papers

Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mec... 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amer E. Alkhalifa United States 9 156 112 99 59 48 16 415
Xiaoting Luo China 12 193 1.2× 81 0.7× 72 0.7× 50 0.8× 23 0.5× 26 477
Xiaowen Shi Japan 15 160 1.0× 117 1.0× 122 1.2× 18 0.3× 30 0.6× 22 451
Aishat Motolani United States 7 179 1.1× 92 0.8× 99 1.0× 32 0.5× 48 1.0× 11 354
Kyung‐Min Han South Korea 9 133 0.9× 90 0.8× 108 1.1× 20 0.3× 44 0.9× 14 336
Pedro A. Dionísio Portugal 12 412 2.6× 150 1.3× 103 1.0× 49 0.8× 39 0.8× 13 722
Samiksha Kukal India 10 142 0.9× 47 0.4× 45 0.5× 99 1.7× 18 0.4× 24 476
Chitra Rawat India 10 142 0.9× 65 0.6× 34 0.3× 86 1.5× 18 0.4× 15 379
Hao-Fei Liu China 6 167 1.1× 77 0.7× 46 0.5× 21 0.4× 32 0.7× 7 306
Yu‐Ping He China 15 153 1.0× 148 1.3× 119 1.2× 36 0.6× 10 0.2× 31 553
Franklyn De Silva Canada 5 164 1.1× 116 1.0× 55 0.6× 28 0.5× 17 0.4× 8 430

Countries citing papers authored by Amer E. Alkhalifa

Since Specialization
Citations

This map shows the geographic impact of Amer E. Alkhalifa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amer E. Alkhalifa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amer E. Alkhalifa more than expected).

Fields of papers citing papers by Amer E. Alkhalifa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amer E. Alkhalifa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amer E. Alkhalifa. The network helps show where Amer E. Alkhalifa may publish in the future.

Co-authorship network of co-authors of Amer E. Alkhalifa

This figure shows the co-authorship network connecting the top 25 collaborators of Amer E. Alkhalifa. A scholar is included among the top collaborators of Amer E. Alkhalifa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amer E. Alkhalifa. Amer E. Alkhalifa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Al-Ghraiybah, Nour F., Amer E. Alkhalifa, Lauren N. Woodie, et al.. (2025). Dose-dependent evaluation of chronic oleocanthal on metabolic phenotypes and organ toxicity in 5xFAD mice. Pharmacological Research - Natural Products. 8. 100357–100357.
3.
Alkhalifa, Amer E., et al.. (2025). Anti-Amyloid Monoclonal Antibodies for Alzheimer’s Disease: Evidence, ARIA Risk, and Precision Patient Selection. Journal of Personalized Medicine. 15(9). 437–437. 5 indexed citations
4.
Alkhalifa, Amer E., Nour F. Al-Ghraiybah, & Amal Kaddoumi. (2024). Extra-Virgin Olive Oil in Alzheimer’s Disease: A Comprehensive Review of Cellular, Animal, and Clinical Studies. International Journal of Molecular Sciences. 25(3). 1914–1914. 24 indexed citations
6.
Rihani, Sweilem B. Al, Hassan Y. Ebrahim, Nour F. Al-Ghraiybah, et al.. (2024). The Usnic Acid Analogue 4-FPBUA Enhances the Blood–Brain Barrier Function and Induces Autophagy in Alzheimer’s Disease Mouse Models. ACS Chemical Neuroscience. 15(17). 3152–3167. 2 indexed citations
7.
Al-Shami, Kamal M., et al.. (2023). Comparison of Oleocanthal-Low EVOO and Oleocanthal against Amyloid-β and Related Pathology in a Mouse Model of Alzheimer’s Disease. Molecules. 28(3). 1249–1249. 16 indexed citations
8.
Alkhalifa, Amer E., et al.. (2023). Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies. International Journal of Molecular Sciences. 24(22). 16288–16288. 102 indexed citations breakdown →
9.
Ayoub, Nehad M., et al.. (2022). Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic Approaches. Frontiers in Pharmacology. 13. 838133–838133. 83 indexed citations
10.
Al-Ghraiybah, Nour F., et al.. (2022). Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease. International Journal of Molecular Sciences. 23(18). 10572–10572. 110 indexed citations
11.
Shatnawi, Aymen, et al.. (2022). Estrogen-Related Receptors Gene Expression and Copy Number Alteration Association With the Clinicopathologic Characteristics of Breast Cancer. Breast Cancer Basic and Clinical Research. 16. 761825273–761825273. 2 indexed citations
13.
Ayoub, Nehad M., et al.. (2021). Overcoming resistance to targeted therapy using MET inhibitors in solid cancers: evidence from preclinical and clinical studies. Medical Oncology. 38(12). 143–143. 7 indexed citations
15.
Shatnawi, Aymen, Nehad M. Ayoub, & Amer E. Alkhalifa. (2020). ING4 Expression Landscape and Association With Clinicopathologic Characteristics in Breast Cancer. Clinical Breast Cancer. 21(4). e319–e331. 9 indexed citations
16.
Al‐Shar’i, Nizar A., et al.. (2019). Discovery of a nanomolar inhibitor of the human glyoxalase-I enzyme using structure-based poly-pharmacophore modelling and molecular docking. Journal of Computer-Aided Molecular Design. 33(9). 799–815. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026